Mr. Guy Chamberland of Tetra reports
TETRA NATURAL HEALTH SIGNS A SUPPLY AGREEMENT WITH NAMASTE TECHNOLOGIES FOR THE MARKETING AND DISTRIBUTION OF RX PRINCEPS, ITS PREMIUM MEDICINAL CANNABIS PRODUCT
Tetra Natural Health, a division of Tetra Bio-Pharma Inc., and Namaste Technologies Inc. have signed a supply agreement for the sale and distribution of Rx Princeps, the medical cannabis brand of Tetra Natural Health. Under the agreement Namaste will purchase Rx Princeps from Tetra Natural Health to be sold through the medical-cannabis-sales-only facility of Namaste's wholly owned subsidiary, Cannmart Inc. The agreement also includes the sales of Tetra Natural Health's specially designed inhalation device, air filters and its Munchies B Gone gum.
Guy Chamberland, interim chief executive officer and chief science officer of Tetra Bio-Pharma, commented: "We are thrilled to have signed this partnership deal with Namaste, who operates as an e-commerce medicinal cannabis distributor with 32 sites in 20 countries, providing substantial exposure for Tetra Natural Health's Rx Princeps brand of premium medicinal cannabis. We believe this is the making of a solid partnership with Tetra Natural Health's ability to produce a quality product combined with Namaste's far-reaching sales and distribution network."
Sean Dollinger, president and chief executive officer of Namaste, commented: "We are very proud to be bringing on a strong supply partner like Tetra Bio-Pharma. Rx Princeps is a unique pharma-based product that we feel will be very valuable for our patients. We have a unique opportunity to develop an exciting platform that will cater specifically to a patient's needs. We plan on providing a single source for all things cannabis, and Cannmart and NamasteMD are key components of that strategy, along with securing the highest-quality cannabis for our patients. We would like to take the opportunity to thank Tetra Bio-Pharma's management team for their support and look forward to a growing future together."
Rx Princeps is a unique blend of three strains of medical cannabis. Its production has been standardized in order to ensure a lot-to-lot consistent composition in its active ingredients (tetrahydrocannabinol and cannabidiol).
About Tetra Bio-Pharma Inc.
Tetra Bio-Pharma is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a clinical program aimed at bringing novel drugs and treatments to patients and their health care providers. The company has several subsidiaries engaged in the development of biopharmaceuticals and natural health products containing cannabis and other medicinal plant-based elements. Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing biopharma industry by regulators, physicians and insurance companies.
About Namaste Technologies Inc.
Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centres around the globe and operates over 30 websites under various brands. The company is focused on patient acquisition through NamasteMD and intends on building Canada's largest database of medical cannabis patients. The company's subsidiary, Cannmart, is an ACMPR (Access to Cannabis for Medical Purposes Regulations) licensed producer with a sales-only licence, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers.
We seek Safe Harbor.
© 2019 Canjex Publishing Ltd. All rights reserved.